Ceramide and ceramide 1-phosphate in health and disease

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Arana, Lide ^a   Gangoiti, Patricia ^a   Ouro, Alberto ^a   Trueba, Miguel ^a   Gómez Muñoz, Antonio ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CERAMIDE; CERAMIDE 1 PHOSPHATASE; CYTOSOLIC PHOSPHOLIPASE A2; PROSTAGLANDIN; SPHINGOLIPID; UNCLASSIFIED DRUG; CERAMIDE 1 PHOSPHATE; CERAMIDE 1-PHOSPHATE; MITOGENIC AGENT;

CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; REVIEW; ANIMAL; CELL MEMBRANE; CHEMOTAXIS; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; PHOSPHORYLATION;

ANIMALS; ARACHIDONIC ACID; CELL MEMBRANE; CERAMIDES; CHEMOTAXIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MACROPHAGES; MICE; MITOGENS; PHOSPHOLIPASES A2, CYTOSOLIC; PHOSPHORYLATION; PROSTAGLANDINS;

EID: 77649122069     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-15     Document Type: Review

References (164)

1. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. W Zheng J Kollmeyer H Symolon A Momin E Munter E Wang S Kelly JC Allegood Y Liu Q Peng, et al. Biochim Biophys Acta 2006 1758 1864 1884 10.1016/j.bbamem.2006.08.009 17052686
2. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. YA Hannun LM Obeid, J Biol Chem 2002 277 25847 25850 10.1074/jbc.R200008200 12011103
3. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. R Kolesnick DW Golde, Cell 1994 77 325 328 10.1016/0092-8674(94) 90147-3 8181053
4. The sphingomyelin cycle and the second messenger function of ceramide. YA Hannun, J Biol Chem 1994 269 3125 3128 8106344
5. Ceramide: an intracellular signal for apoptosis. YA Hannun LM Obeid, Trends Biochem Sci 1995 20 73 77 10.1016/S0968-0004(00)88961-6 7701566
6. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. KA Dressler S Mathias RN Kolesnick, Science 1992 255 1715 1718 10.1126/science.1313189 1313189
7. Modulation of cell signalling by ceramides. A Gomez-Munoz, Biochim Biophys Acta 1998 1391 92 109 9518566
8. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha. S Mathias KA Dressler RN Kolesnick, Proc Natl Acad Sci USA 1991 88 10009 10013 10.1073/pnas.88.22.10009 1946418
9. Ceramide: a novel second messenger. S Mathias R Kolesnick, Adv Lipid Res 1993 25 65 90 8368154
10. Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. T Okazaki A Bielawska RM Bell YA Hannun, J Biol Chem 1990 265 15823 15831 2394750
11. Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action. DS Menaldino A Bushnev A Sun DC Liotta H Symolon K Desai DL Dillehay Q Peng E Wang J Allegood, et al. Pharmacol Res 2003 47 373 381 10.1016/S1043-6618(03)00054-9 12676511
12. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. JM Adams T Pratipanawatr R Berria E Wang RA DeFronzo MC Sullards LJ Mandarino, Diabetes 2004 53 25 31 10.2337/diabetes.53.1.25 14693694
13. Protein kinase C and lipid-induced insulin resistance in skeletal muscle. C Schmitz-Peiffer, Ann NY Acad Sci 2002 967 146 157 12079844
14. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. S Stratford KL Hoehn F Liu SA Summers, J Biol Chem 2004 279 36608 36615 10.1074/jbc.M406499200 15220355
15. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. AH Merrill Jr, J Biol Chem 2002 277 25843 25846 10.1074/jbc.R200009200 12011104
16. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. AH Merrill Jr MC Sullards JC Allegood S Kelly E Wang, Methods 2005 36 207 224 10.1016/j.ymeth.2005.01.009 15894491
17. Observation of different ceramide species from crude cellular extracts by normal-phase high-performance liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. BJ Pettus A Bielawska BJ Kroesen PD Moeller ZM Szulc YA Hannun M Busman, Rapid Commun Mass Spectrom 2003 17 1203 1211 10.1002/rcm.1043 12772277
18. Ceramide-1-phosphate: a novel regulator of cell activation. A Gomez-Munoz, FEBS Lett 2004 562 5 10 10.1016/S0014-5793(04)00211-X 15069950
19. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. CE Chalfant S Spiegel, J Cell Sci 2005 118 4605 4612 10.1242/jcs.02637 16219683
20. Ceramide-1-phosphate: the "missing" link in eicosanoid biosynthesis and inflammation. NF Lamour CE Chalfant, Mol Interv 2005 5 358 367 10.1124/mi.5.6.8 16394251
21. Ceramide 1-phosphate, a mediator of phagocytosis. V Hinkovska-Galcheva LA Boxer A Kindzelskii M Hiraoka A Abe S Goparju S Spiegel HR Petty JA Shayman, J Biol Chem 2005 280 26612 26621 10.1074/jbc.M501359200 15899891
22. The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. VT Hinkovska-Galcheva LA Boxer PJ Mansfield D Harsh A Blackwood JA Shayman, J Biol Chem 1998 273 33203 33209 10.1074/jbc.273.50. 33203 9837889
23. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. Y Pewzner-Jung S Ben-Dor AH Futerman, J Biol Chem 2006 281 25001 25005 10.1074/jbc.R600010200 16793762
24. Principles of bioactive lipid signalling: lessons from sphingolipids. YA Hannun LM Obeid, Nat Rev Mol Cell Biol 2008 9 139 150 10.1038/nrm2329 18216770
25. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. K Desai MC Sullards J Allegood E Wang EM Schmelz M Hartl HU Humpf DC Liotta Q Peng AH Merrill Jr, Biochim Biophys Acta 2002 1585 188 192 12531553
26. Compartmentalization of ceramide signaling: physical foundations and biological effects. RN Kolesnick FM Goni A Alonso, J Cell Physiol 2000 184 285 300 10.1002/1097-4652(200009)184:3<285::AID-JCP23.0.CO;2-3 10911359
27. Sphingomyelinases: enzymology and membrane activity. FM Goni A Alonso, FEBS Lett 2002 531 38 46 10.1016/S0014-5793(02)03482-8 12401200
28. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? AE Cremesti FM Goni R Kolesnick, FEBS Lett 2002 531 47 53 10.1016/S0014-5793(02)03489-0 12401201
29. Glycosphingolipids and drug resistance. V Gouaze-Andersson MC Cabot, Biochim Biophys Acta 2006 1758 2096 2103 10.1016/j.bbamem.2006.08.012 17010304
30. Ceramide 1-phosphate/ceramide, a switch between life and death. A Gomez-Munoz, Biochim Biophys Acta 2006 1758 2049 2056 10.1016/j.bbamem.2006.05. 011 16808893
31. Sphingolipids in inflammation: roles and implications. BJ Pettus CE Chalfant YA Hannun, Curr Mol Med 2004 4 405 418 10.2174/1566524043360573 15354871
32. Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells. E Hertervig A Nilsson Y Cheng RD Duan, J Cancer Res Clin Oncol 2003 129 577 582 10.1007/s00432-003- 0466-2 12920578
33. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. RD Duan A Nilsson, Prog Lipid Res 2009 48 62 72 10.1016/j.plipres.2008.04.003 19027789
34. Activation of protein kinase C-alpha is essential for stimulation of cell proliferation by ceramide 1-phosphate. P Gangoiti MH Granado L Arana A Ouro A Gomez-Munoz, FEBS Lett 2010 584 3 517 24 Epub 2009 Nov 27 10.1016/j.febslet. 2009.11.086 19948174
35. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. YA Hannun CR Loomis AH Merrill Jr RM Bell, J Biol Chem 1986 261 12604 12609 3462188
36. Changing J774A.1 cells to new medium perturbs multiple signaling pathways, including the modulation of protein kinase C by endogenous sphingoid bases. ER Smith PL Jones JM Boss AH Merrill Jr, J Biol Chem 1997 272 5640 5646 10.1074/jbc.272.9.5640 9038174
37. Effects of sphingosine, albumin and unsaturated fatty acids on the activation and translocation of phosphatidate phosphohydrolases in rat hepatocytes. A Gomez-Munoz EH Hamza DN Brindley, Biochim Biophys Acta 1992 1127 49 56 1320939
38. Plasma membrane fractions from rat liver contain a phosphatidate phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol. Z Jamal A Martin A Gomez-Munoz DN Brindley, J Biol Chem 1991 266 2988 2996 1993672
39. Activation of endothelial cell phospholipase D by sphingosine and sphingosine-1-phosphate. V Natarajan HN Jayaram WM Scribner JG Garcia, Am J Respir Cell Mol Biol 1994 11 221 229 8049083
40. Different effects of sphingosine, R59022 and anionic amphiphiles on two diacylglycerol kinase isozymes purified from porcine thymus cytosol. F Sakane K Yamada H Kanoh, FEBS Lett 1989 255 409 413 10.1016/0014-5793(89)81134-2 2551742
41. Sphingosine activates cellular diacylglycerol kinase in intact Jurkat cells, a human T-cell line. K Yamada F Sakane S Imai H Takemura, Biochim Biophys Acta 1993 1169 217 224 7548113 (Pubitemid 23264876)
42. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. H Liu M Sugiura VE Nava LC Edsall K Kono S Poulton S Milstien T Kohama S Spiegel, J Biol Chem 2000 275 19513 19520 10.1074/jbc.M002759200 10751414
43. Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. AN Urs E Dammer MB Sewer, Endocrinology 2006 147 5249 5258 10.1210/en.2006-0355 16887917
44. Sphingosine 1-phosphate signaling: providing cells with a sense of direction. S Spiegel D English S Milstien, Trends Cell Biol 2002 12 236 242 10.1016/S0962-8924(02)02277-8 12062172
45. Sphingosine-1-phosphate: an enigmatic signalling lipid. S Spiegel S Milstien, Nat Rev Mol Cell Biol 2003 4 397 407 10.1038/nrm1103 12728273
46. Sphingosine 1-phosphate, a key cell signaling molecule. S Spiegel S Milstien, J Biol Chem 2002 277 25851 25854 10.1074/jbc.R200007200 12011102
47. Sphingosine-1-phosphate stimulates cortisol secretion. M Rabano A Pena L Brizuela A Marino JM Macarulla M Trueba A Gomez-Munoz, FEBS Lett 2003 535 101 105 10.1016/S0014-5793(02)03882-6 12560086
48. Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion. L Brizuela M Rabano A Pena P Gangoiti JM Macarulla M Trueba A Gomez-Munoz, J Lipid Res 2006 47 1238 1249 10.1194/jlr.M500510-JLR200 16554657
49. Sphingosine kinase: biochemical and cellular regulation and role in disease. TA Taha YA Hannun LM Obeid, J Biochem Mol Biol 2006 39 113 131 16584625
50. Cell regulation by sphingosine and more complex sphingolipids. AH Merrill Jr, J Bioenerg Biomembr 1991 23 83 104 2010436
51. An update of the enzymology and regulation of sphingomyelin metabolism. AH Merrill Jr DD Jones, Biochim Biophys Acta 1990 1044 1 12 2187537
52. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. AH Merrill Jr EM Schmelz DL Dillehay S Spiegel JA Shayman JJ Schroeder RT Riley KA Voss E Wang, Toxicol Appl Pharmacol 1997 142 208 225 10.1006/taap.1996.8029 9007051
53. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. R Kolesnick, J Clin Invest 2002 110 3 8 12093880
54. 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. RN Kolesnick, J Biol Chem 1987 262 16759 16762 3479432
55. Characterization of a ceramide kinase activity from human leukemia (HL-60) cells. Separation from diacylglycerol kinase activity. RN Kolesnick MR Hemer, J Biol Chem 1990 265 18803 18808 2172234
56. Functions of ceramide in coordinating cellular responses to stress. YA Hannun, Science 1996 274 1855 1859 10.1126/science.274.5294.1855 8943189
57. Molecular machinery for non-vesicular trafficking of ceramide. K Hanada K Kumagai S Yasuda Y Miura M Kawano M Fukasawa M Nishijima, Nature 2003 426 803 809 10.1038/nature02188 14685229
58. Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells. A Huwiler D Fabbro J Pfeilschifter, Biochemistry 1998 37 14556 14562 10.1021/bi981401i 9772184
59. HSP27 in signal transduction and association with contractile proteins in smooth muscle cells. AI Ibitayo J Sladick S Tuteja O Louis-Jacques H Yamada G Groblewski M Welsh KN Bitar, Am J Physiol 1999 277 445 454 10444459
60. Ceramide-induced translocation of protein kinase C-delta and -epsilon to the cytosol. Implications in apoptosis. H Sawai T Okazaki Y Takeda M Tashima H Sawada M Okuma S Kishi H Umehara N Domae, J Biol Chem 1997 272 2452 2458 10.1074/jbc.272.4.2452 8999958
61. Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. M Sumitomo M Ohba J Asakuma T Asano T Kuroki T Asano M Hayakawa, J Clin Invest 2002 109 827 836 11901191
62. Ceramide-induced apoptosis by translocation, phosphorylation, and activation of protein kinase Cdelta in the Golgi complex. T Kajimoto Y Shirai N Sakai T Yamamoto H Matsuzaki U Kikkawa N Saito, J Biol Chem 2004 279 12668 12676 10.1074/jbc.M312350200 14715667
63. Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts. A Gomez-Munoz A Martin L O'Brien DN Brindley, J Biol Chem 1994 269 8937 8943 8132631
64. Interaction of ceramides, sphingosine, and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity. A Gomez-Munoz DW Waggoner L O'Brien DN Brindley, J Biol Chem 1995 270 26318 26325 10.1074/jbc.270.44. 26318 7592842
65. Stimulation of phospholipase D activity by oxidized LDL in mouse peritoneal macrophages. A Gomez-Munoz JS Martens UP Steinbrecher, Arterioscler Thromb Vasc Biol 2000 20 135 143 10634810
66. Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages. A Gomez-Munoz L O'Brien R Hundal UP Steinbrecher, J Lipid Res 1999 40 988 993 10357830
67. The platelet-activating factor receptor antagonist L-659,989 inhibits phospholipase D activity. A Gomez-Munoz L O'Brien UP Steinbrecher, Biochim Biophys Acta 1999 1438 247 252 10320807
68. Angiotensin II-stimulated cortisol secretion is mediated by phospholipase D. M Rabano A Pena L Brizuela JM Macarulla A Gomez-Munoz M Trueba, Mol Cell Endocrinol 2004 222 9 20 10.1016/j.mce.2004.05.006 15249121
69. Phospholipase D in cellular senescence. ME Venable LM Obeid, Biochim Biophys Acta 1999 1439 291 298 10425402
70. Activation of phospholipase D-2 by P2X(7) agonists in rat submandibular gland acini. E Perez-Andres M Fernandez-Rodriguez M Gonzalez A Zubiaga A Vallejo I Garcia C Matute S Pochet JP Dehaye M Trueba, et al. J Lipid Res 2002 43 1244 1255 12177168
71. Cell-permeable ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and RhoA. A Abousalham C Liossis L O'Brien DN Brindley, J Biol Chem 1997 272 1069 1075 10.1074/jbc.272.2.1069 8995404
72. Ceramide inhibits phospholipase D in a cell-free system. ME Venable A Bielawska LM Obeid, J Biol Chem 1996 271 24800 24805 10.1074/jbc.271.40.24800 8798752
73. Acid sphingomyelinase in macrophage apoptosis. UP Steinbrecher A Gomez-Munoz V Duronio, Curr Opin Lipidol 2004 15 531 537 10.1097/00041433- 200410000-00006 15361788
74. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. MM Kockx GR De Meyer N Buyssens MW Knaapen H Bult AG Herman, Circ Res 1998 83 378 387 9721694
75. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. C Mao LM Obeid, Biochim Biophys Acta 2008 1781 424 434 18619555
76. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. N Auge M Nikolova-Karakashian S Carpentier S Parthasarathy A Negre-Salvayre R Salvayre AH Merrill Jr T Levade, J Biol Chem 1999 274 21533 21538 10.1074/jbc.274.31.21533 10419457
77. Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels. K Geoffroy L Troncy N Wiernsperger M Lagarde S El Bawab, FEBS Lett 2005 579 1249 1254 10.1016/j.febslet.2004.12.094 15710421
78. Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids. K Geoffroy N Wiernsperger M Lagarde S El Bawab, J Biol Chem 2004 279 34343 34352 10.1074/jbc.M403273200 15184394
79. Ceramide accumulation during oxidant renal tubular injury: mechanisms and potential consequences. RA Zager DS Conrad K Burkhart, J Am Soc Nephrol 1998 9 1670 1680 9727376
80. Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells. C Partovian R Ju ZW Zhuang KA Martin M Simons, Mol Cell 2008 32 140 149 10.1016/j.molcel.2008. 09.010 18851840
81. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. M Straczkowski I Kowalska M Baranowski A Nikolajuk E Otziomek P Zabielski A Adamska A Blachnio J Gorski M Gorska, Diabetologia 2007 50 2366 2373 10.1007/s00125-007-0781-2 17724577
82. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. F Samad KD Hester G Yang YA Hannun J Bielawski, Diabetes 2006 55 2579 2587 10.2337/db06-0330 16936207
83. Effects of Streptozotocin-induced Diabetes and Elevation of Plasma FFA on Ceramide Metabolism in Rat Skeletal Muscle. A Blachnio-Zabielska P Zabielski M Baranowski J Gorski, Horm Metab Res 2010 42 1 7 10.1055/s-0029-1238322 19753513
84. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. JA Chavez WL Holland J Bar K Sandhoff SA Summers, J Biol Chem 2005 280 20148 20153 10.1074/jbc.M412769200 15774472
85. Nitric oxide induces degradation of the neutral ceramidase in rat renal mesangial cells and is counterregulated by protein kinase C. R Franzen D Fabbro A Aschrafi J Pfeilschifter A Huwiler, J Biol Chem 2002 277 46184 46190 10.1074/jbc.M204034200 12359735 (Pubitemid 35417609)
86. Nitric oxide induces neutral ceramidase degradation by the ubiquitin/proteasome complex in renal mesangial cell cultures. R Franzen J Pfeilschifter A Huwiler, FEBS Lett 2002 532 441 444 10.1016/S0014-5793(02)03727- 4 12482609 (Pubitemid 35441390)
87. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. K Pahan FG Sheikh M Khan AM Namboodiri I Singh, J Biol Chem 1998 273 2591 2600 10.1074/jbc.273.5.2591 9446561
88. Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes. A Amadou A Nawrocki M Best-Belpomme C Pavoine F Pecker, Am J Physiol Cell Physiol 2002 282 1339 1347 11997249
89. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. Y Hatano H Terashi S Arakawa K Katagiri, J Invest Dermatol 2005 124 786 792 10.1111/j.0022-202X.2005.23651.x 15816837
90. Leptin modulates the negative inotropic effect of interleukin-1beta in cardiac myocytes. MJ Radin BJ Holycross C Dumitrescu R Kelley RA Altschuld, Mol Cell Biochem 2008 315 179 184 10.1007/s11010-008-9805-6 18535786
91. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. H Oral GW Dorn DL Mann, J Biol Chem 1997 272 4836 4842 10.1074/jbc.272.8.4836 9030540
92. Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. CI Lin CN Chen JH Chen H Lee, J Cell Biochem 2006 99 1216 1232 10.1002/jcb.20963 16795034
93. Negative regulation of interleukin-1beta-activated neutral sphingomyelinase by protein kinase C in rat mesangial cells. M Kaszkin A Huwiler K Scholz H van den Bosch J Pfeilschifter, FEBS Lett 1998 440 163 166 10.1016/S0014-5793(98)01445-8 9862447
94. Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells. R Franzen A Pautz L Brautigam G Geisslinger J Pfeilschifter A Huwiler, J Biol Chem 2001 276 35382 35389 10.1074/jbc.M102153200 11457826
95. Molecular targeting of acid ceramidase: implications to cancer therapy. YH Zeidan RW Jenkins JB Korman X Liu LM Obeid JS Norris YA Hannun, Curr Drug Targets 2008 9 653 661 10.2174/138945008785132358 18691012
96. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. Y Osawa H Uchinami J Bielawski RF Schwabe YA Hannun DA Brenner, J Biol Chem 2005 280 27879 27887 10.1074/jbc.M503002200 15946935
97. Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. A Strelow K Bernardo S Adam-Klages T Linke K Sandhoff M Kronke D Adam, J Exp Med 2000 192 601 612 10.1084/jem.192.5.601 10974027
98. Prenatal alcohol exposure increases TNFalpha-induced cytotoxicity in primary astrocytes. WJ De Vito K Xhaja S Stone, Alcohol 2000 21 63 71 10.1016/S0741-8329(00)00078-1 10946159
99. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11. M Nikolova-Karakashian ET Morgan C Alexander DC Liotta AH Merrill Jr, J Biol Chem 1997 272 18718 18724 10.1074/jbc.272.30.18718 9228043
100. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. E Coroneos M Martinez S McKenna M Kester, J Biol Chem 1995 270 23305 23309 10.1074/jbc.270.40.23305 7559485
101. Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts. SG Payne DN Brindley LJ Guilbert, J Cell Physiol 1999 180 263 270 10.1002/(SICI)1097-4652(199908)180: 2<263::AID-JCP143.0.CO;2-H 10395296
102. Acid ceramidase is a novel factor required for early embryo survival. E Eliyahu JH Park N Shtraizent X He EH Schuchman, FASEB J 2007 21 1403 1409 10.1096/fj.06-7016com 17264167
103. Ceramidase enhances phospholipase C-induced hemolysis by Pseudomonas aeruginosa. N Okino M Ito, J Biol Chem 2007 282 6021 6030 10.1074/jbc.M603088200 17202150
104. Acid ceramidase inhibition: a novel target for cancer therapy. X Liu S Elojeimy LS Turner AE Mahdy YH Zeidan A Bielawska J Bielawski JY Dong AM El-Zawahry GW Guo, et al. Front Biosci 2008 13 2293 2298 10.2741/2843 17981711
105. Acid ceramidase and human disease. JH Park EH Schuchman, Biochim Biophys Acta 2006 1758 2133 2138 10.1016/j.bbamem.2006.08.019 17064658
106. Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy. S Elojeimy X Liu JC McKillop AM El-Zawahry DH Holman JY Cheng WD Meacham AE Mahdy AF Saad LS Turner, et al. Mol Ther 2007 15 1259 1263 10.1038/sj.mt.6300167 17426710
107. Human acid ceramidase is overexpressed but not mutated in prostate cancer. RS Seelan C Qian A Yokomizo DG Bostwick DI Smith W Liu, Genes Chromosomes Cancer 2000 29 137 146 10.1002/1098-2264(2000)9999:9999<::AID- GCC10183.0.CO;2-E 10959093
108. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. DK Perry J Carton AK Shah F Meredith DJ Uhlinger YA Hannun, J Biol Chem 2000 275 9078 9084 10.1074/jbc.275.12.9078 10722759
109. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. E Ruckhaberle A Rody K Engels R Gaetje G von Minckwitz S Schiffmann S Grosch G Geisslinger U Holtrich T Karn M Kaufmann, Breast Cancer Res Treat 2008 112 41 52 10.1007/s10549-007- 9836-9 18058224
110. Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer. E Ruckhaberle U Holtrich K Engels L Hanker R Gatje D Metzler T Karn M Kaufmann A Rody, Climacteric 2009 1 12 10.1080/ 13697130902939913 19657789
111. The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy. AF Saad WD Meacham A Bai V Anelli S Elojeimy AE Mahdy LS Turner J Cheng A Bielawska J Bielawski, et al. Cancer Biol Ther 2007 6 1455 1460 17881906
112. Synaptic vesicle ceramide kinase. A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles. SM Bajjalieh TF Martin E Floor, J Biol Chem 1989 264 14354 14360 2547795
113. Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells. S Mitsutake TJ Kim Y Inagaki M Kato T Yamashita Y Igarashi, J Biol Chem 2004 279 17570 17577 10.1074/jbc.M312885200 14769792
114. Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin. A Boath C Graf E Lidome T Ullrich P Nussbaumer F Bornancin, J Biol Chem 2008 283 8517 8526 10.1074/jbc.M707107200 18086664
115. Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis. NF Lamour RV Stahelin DS Wijesinghe M Maceyka E Wang JC Allegood AH Merrill Jr W Cho CE Chalfant, J Lipid Res 2007 48 1293 1304 10.1194/jlr.M700083-JLR200 17392267
116. The role of sphingosine and ceramide kinases in inflammatory responses. T Baumruker F Bornancin A Billich, Immunol Lett 2005 96 175 185 10.1016/j.imlet.2004.09.001 15585321
117. Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. A Gomez-Munoz JY Kong B Salh UP Steinbrecher, J Lipid Res 2004 45 99 105 10.1194/jlr.M300158-JLR200 14523050
118. Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization. M Sugiura K Kono H Liu T Shimizugawa H Minekura S Spiegel T Kohama, J Biol Chem 2002 277 23294 23300 10.1074/jbc.M201535200 11956206
119. The leucine 10 residue in the pleckstrin homology domain of ceramide kinase is crucial for its catalytic activity. TJ Kim S Mitsutake M Kato Y Igarashi, FEBS Lett 2005 579 4383 4388 10.1016/j.febslet.2005.06.079 16081073
120. The interaction between the pleckstrin homology domain of ceramide kinase and phosphatidylinositol 4,5-bisphosphate regulates the plasma membrane targeting and ceramide 1-phosphate levels. TJ Kim S Mitsutake Y Igarashi, Biochem Biophys Res Commun 2006 342 611 617 10.1016/j.bbrc.2006.01.170 16488390
121. A conserved cysteine motif essential for ceramide kinase function. E Lidome C Graf M Jaritz A Schanzer P Rovina R Nikolay F Bornancin, Biochimie 2008 90 1560 1565 10.1016/j.biochi.2008.07.001 18662741
122. Subcellular localization of ceramide kinase and ceramide kinase-like protein requires interplay of their Pleckstrin Homology domain-containing N-terminal regions together with C-terminal domains. P Rovina A Schanzer C Graf D Mechtcheriakova M Jaritz F Bornancin, Biochim Biophys Acta 2009 1791 1023 1030 19501188
123. Substrate specificity of human ceramide kinase. DS Wijesinghe A Massiello P Subramanian Z Szulc A Bielawska CE Chalfant, J Lipid Res 2005 46 2706 2716 10.1194/jlr.M500313-JLR200 16170208
124. On the presence of C2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinase. H Van Overloop Y Denizot M Baes PP Van Veldhoven, Biol Chem 2007 388 315 324 10.1515/BC.2007.035 17338639
125. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides. A Gomez-Munoz PA Duffy A Martin L O'Brien HS Byun R Bittman DN Brindley, Mol Pharmacol 1995 47 833 839 7746276
126. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. BJ Pettus A Bielawska S Spiegel P Roddy YA Hannun CE Chalfant, J Biol Chem 2003 278 38206 38213 10.1074/jbc.M304816200 12855693
127. Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26). M Tuson G Marfany R Gonzalez-Duarte, Am J Hum Genet 2004 74 128 138 10.1086/381055 14681825
128. Neutropenia with Impaired Immune Response to Streptococcus pneumoniae in Ceramide Kinase-Deficient Mice. C Graf B Zemann P Rovina N Urtz A Schanzer R Reuschel D Mechtcheriakova M Muller E Fischer C Reichel, et al. J Immunol 2008 180 3457 3466 18292572
129. Characterization of a ceramide kinase-like protein. F Bornancin D Mechtcheriakova S Stora C Graf A Wlachos P Devay N Urtz T Baumruker A Billich, Biochim Biophys Acta 2005 1687 31 43 15708351
130. Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways. P Gangoiti MH Granado SW Wang JY Kong UP Steinbrecher A Gomez-Munoz, Cell Signal 2008 20 726 736 10.1016/j.cellsig.2007.12.008 18234473
131. Stimulation of DNA synthesis by natural ceramide 1-phosphate. A Gomez-Munoz LM Frago L Alvarez I Varela-Nieto, Biochem J 1997 325 Pt 2 435 440 9230125
132. Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway. A Gomez-Munoz JY Kong K Parhar SW Wang P Gangoiti M Gonzalez S Eivemark B Salh V Duronio UP Steinbrecher, FEBS Lett 2005 579 3744 3750 10.1016/j.febslet.2005.05.067 15978590
133. Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells. P Mitra M Maceyka SG Payne N Lamour S Milstien CE Chalfant S Spiegel, FEBS Lett 2007 581 735 740 10.1016/j.febslet.2007.01.041 17274985
134. Enhanced ceramide-induced apoptosis in ceramide kinase overexpressing cells. C Graf P Rovina L Tauzin A Schanzer F Bornancin, Biochem Biophys Res Commun 2007 354 309 314 10.1016/j.bbrc.2006.12.208 17222802
135. Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL levels. RS Hundal A Gomez-Munoz JY Kong BS Salh A Marotta V Duronio UP Steinbrecher, J Biol Chem 2003 278 24399 24408 10.1074/jbc.M209179200 12750385
136. Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. A Gomez-Munoz J Kong B Salh UP Steinbrecher, FEBS Lett 2003 539 56 60 10.1016/S0014-5793(03)00197-2 12650926
137. Ceramide 1-phosphate inhibits serine palmitoyltransferase and blocks apoptosis in alveolar macrophages. MH Granado P Gangoiti A Ouro L Arana A Gomez-Munoz, Biochim Biophys Acta 2009 1791 263 272 19416641
138. Acid sphingomyelinase and inhibition by phosphate ion: role of inhibition by phosphatidyl-myo-inositol 3,4,5-triphosphate in oligodendrocyte cell signaling. FD Testai MA Landek R Goswami M Ahmed G Dawson, J Neurochem 2004 89 636 644 10.1046/j.1471-4159.2004.02374.x 15086520
139. Unravelling the activation mechanisms of protein kinase B/Akt. MP Scheid JR Woodgett, FEBS Lett 2003 546 108 112 10.1016/S0014-5793(03)00562-3 12829245
140. Phosphatidylinositol (3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation; phosphatidylinositol (3,4)P2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice. MP Scheid M Huber JE Damen M Hughes V Kang P Neilsen GD Prestwich G Krystal V Duronio, J Biol Chem 2002 277 9027 9035 10.1074/jbc.M106755200 11781306
141. cAMP stimulates protein kinase B in a Wortmannin-insensitive manner. CL Sable N Filippa B Hemmings E Van Obberghen, FEBS Lett 1997 409 253 257 10.1016/S0014-5793(97)00518-8 9202156
142. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. N Filippa CL Sable C Filloux B Hemmings E Van Obberghen, Mol Cell Biol 1999 19 4989 5000 10373549
143. P2Y12 receptor signalling towards PKB proceeds through IGF-I receptor cross-talk and requires activation of Src, Pyk2 and Rap1. K Van Kolen K Gilany L Moens EL Esmans H Slegers, Cell Signal 2006 18 1169 1181 10.1016/j.cellsig. 2005.09.005 16236484
144. Lipid mediator networks in cell signaling: update and impact of cytokines. CN Serhan JZ Haeggstrom CC Leslie, Faseb J 1996 10 1147 1158 8751717
145. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. SK Manna BB Aggarwal, J Immunol 1998 161 2863 2872 9743347
146. Ceramide induction of COX-2 and PGE(2) in pulmonary A549 cells does not involve activation of NF-kappaB. R Newton L Hart KF Chung PJ Barnes, Biochem Biophys Res Commun 2000 277 675 679 10.1006/bbrc.2000.3722 11062012
147. Role of ceramide in stimulation of the transcription of cytosolic phospholipase A2 and cyclooxygenase 2. M Hayakawa S Jayadev M Tsujimoto YA Hannun F Ito, Biochem Biophys Res Commun 1996 220 681 686 10.1006/bbrc.1996.0464 8607825
148. Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation. E Masini L Giannini S Nistri L Cinci R Mastroianni W Xu SA Comhair D Li S Cuzzocrea GM Matuschak D Salvemini, J Pharmacol Exp Ther 2008 324 548 557 10.1124/jpet.107.131565 18042827
149. Ceramide elevates 12-hydroxyeicosatetraenoic acid levels and upregulates 12-lipoxygenase in rat primary hippocampal cell cultures containing predominantly astrocytes. VV Prasad K Nithipatikom DR Harder, Neurochem Int 2008 53 220 229 10.1016/j.neuint.2008.07.002 18680775
150. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. R Goggel S Winoto-Morbach G Vielhaber Y Imai K Lindner L Brade H Brade S Ehlers AS Slutsky S Schutze, et al. Nat Med 2004 10 155 160 10.1038/nm977 14704790
151. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. BJ Pettus A Bielawska P Subramanian DS Wijesinghe M Maceyka CC Leslie JH Evans J Freiberg P Roddy YA Hannun CE Chalfant, J Biol Chem 2004 279 11320 11326 10.1074/jbc.M309262200 14676210
152. Ceramide 1-phosphate acts as a positive allosteric activator of group IVA cytosolic phospholipase A2 alpha and enhances the interaction of the enzyme with phosphatidylcholine. P Subramanian RV Stahelin Z Szulc A Bielawska W Cho CE Chalfant, J Biol Chem 2005 280 17601 17607 10.1074/jbc.M414173200 15743759
153. The coordination of prostaglandin E2 production by sphingosine-1- phosphate and ceramide-1-phosphate. BJ Pettus K Kitatani CE Chalfant TA Taha T Kawamori J Bielawski LM Obeid YA Hannun, Mol Pharmacol 2005 68 330 335 15900018
154. Ceramide kinase and ceramide-1-phosphate. DS Wijesinghe NF Lamour A Gomez-Munoz CE Chalfant, Methods Enzymol 2007 434 265 292 full text 17954253
155. Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor. MH Granado P Gangoiti A Ouro L Arana M Gonzalez M Trueba A Gomez-Munoz, Cell Signal 2009 21 405 412 10.1016/j.cellsig.2008.11.003 19041940
156. Raft ceramide in molecular medicine. E Gulbins R Kolesnick, Oncogene 2003 22 7070 7077 10.1038/sj.onc.1207146 14557812
157. Macrophages and neurodegeneration. JJ Hendriks CE Teunissen HE de Vries CD Dijkstra, Brain Res Brain Res Rev 2005 48 185 195 10.1016/j.brainresrev.2004. 12.008 15850657
158. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. J Condeelis JW Pollard, Cell 2006 124 263 266 10.1016/j.cell.2006. 01.007 16439202
159. Caged ceramide 1-phosphate analogues: synthesis and properties. RS Lankalapalli A Ouro L Arana A Gomez-Munoz R Bittman, J Org Chem 2009 74 8844 8847 10.1021/jo902076w 19908915
160. Suppression of mast cell degranulation by a novel ceramide kinase inhibitor, the F-12509A olefin isomer K1. JW Kim Y Inagaki S Mitsutake N Maezawa S Katsumura YW Ryu CS Park M Taniguchi Y Igarashi, Biochim Biophys Acta 2005 1738 82 90 16352467
161. Targeting ceramide metabolism with a potent and specific ceramide kinase inhibitor. C Graf M Klumpp M Habig P Rovina A Billich T Baumruker B Oberhauser F Bornancin, Mol Pharmacol 2008 74 925 932 10.1124/mol.108.048652 18612076
162. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. Y Lavie H Cao A Volner A Lucci TY Han V Geffen AE Giuliano MC Cabot, J Biol Chem 1997 272 1682 1687 10.1074/jbc.272.3. 1682 8999846
163. Tamoxifen retards glycosphingolipid metabolism in human cancer cells. MC Cabot AE Giuliano A Volner TY Han, FEBS Lett 1996 394 129 131 10.1016/0014-5793(96)00942-8 8843149
164. A ceramide-1-phosphate analogue, PCERA-1, simultaneously suppresses tumour necrosis factor-alpha and induces interleukin-10 production in activated macrophages. M Goldsmith D Avni G Levy-Rimler R Mashiach O Ernst M Levi B Webb MM Meijler NS Gray H Rosen T Zor, Immunology 2008